Shandong Wohua Pharmaceutical Co., Ltd. (002107) Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Shandong Wohua Pharmaceutical Co., Ltd.

Why is Shandong Wohua Pharmaceutical Co., Ltd. ?

Poor long term growth as Net Sales has grown by an annual rate of -4.69% and Operating profit at -12.59% over the last 5 years

The company has declared Positive results for the last 3 consecutive quarters

ROCE(HY) Highest at 15.68%
INTEREST COVERAGE RATIO(Q) Highest at 420,439.78
RAW MATERIAL COST(Y) Fallen by -8.27% (YoY)

With ROE of 15.55%, it has a expensive valuation with a 5.04 Price to Book Value

Over the past year, while the stock has generated a return of 5.44%, its profits have risen by 123.2% ; the PEG ratio of the company is 0.3

Underperformed the market in the last 1 year

The stock has generated a return of 5.44% in the last 1 year, much lower than market (China Shanghai Composite) returns of 23.91%

Real-Time Research Report

Verdict Report

How much should you hold?

Overall Portfolio exposure to Shandong Wohua Pharmaceutical Co., Ltd. should be less than 10%
Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is Shandong Wohua Pharmaceutical Co., Ltd. for you?

High Risk, High Return

Absolute

Risk Adjusted

Volatility

Shandong Wohua Pharmaceutical Co., Ltd.

8.05%

1.00

42.21%

China Shanghai Composite

21.43%

1.73

13.79%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

-4.69%

EBIT Growth (5y)

-12.59%

EBIT to Interest (avg)

56.40

Debt to EBITDA (avg)

Net Debt to Equity (avg)

-0.56

Sales to Capital Employed (avg)

1.12

Tax Ratio

18.74%

Dividend Payout Ratio

160.43%

Pledged Shares

Institutional Holding

ROCE (avg)

24.88%

ROE (avg)

12.98%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

5.04

EV to EBIT

27.27

EV to EBITDA

22.59

EV to Capital Employed

9.99

EV to Sales

3.71

PEG Ratio

0.26

Dividend Yield

4.51%

ROCE (Latest)

36.65%

ROE (Latest)

15.55%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Bearish

Bullish

RSI

No Signal

Bollinger Bands

Mildly Bearish

Mildly Bullish

Moving Averages

Mildly Bullish (Daily)

KST

Bearish

Bullish

Dow Theory

Mildly Bearish

OBV

Mildly Bearish

Mildly Bullish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

18What is working for the Company

ROCE(HY)

Highest at 15.68%

INTEREST COVERAGE RATIO(Q)

Highest at 420,439.78

RAW MATERIAL COST(Y)

Fallen by -8.27% (YoY

DEBTORS TURNOVER RATIO(HY)

Highest at 11.98 times

NET SALES(Q)

Highest at CNY 219.05 MM

OPERATING PROFIT(Q)

Highest at CNY 42.22 MM

PRE-TAX PROFIT(Q)

Highest at CNY 43.89 MM

NET PROFIT(Q)

Highest at CNY 36.65 MM

EPS(Q)

Highest at CNY 0.06

-3What is not working for the Company

INTEREST(9M)

At CNY 0.04 MM has Grown at 22.02%

Here's what is working for Shandong Wohua Pharmaceutical Co., Ltd.

Interest Coverage Ratio

Highest at 420,439.78

in the last five periods

MOJO Watch

The company's ability to manage interest payments is improving

Operating Profit to Interest

Net Sales

Highest at CNY 219.05 MM

in the last five periods

MOJO Watch

Near term sales trend is positive

Net Sales (CNY MM)

Operating Profit

Highest at CNY 42.22 MM

in the last five periods

MOJO Watch

Near term Operating Profit trend is positive

Operating Profit (CNY MM)

Pre-Tax Profit

Highest at CNY 43.89 MM

in the last five periods

MOJO Watch

Near term Pre-Tax Profit trend is positive

Pre-Tax Profit (CNY MM)

Pre-Tax Profit

At CNY 43.89 MM has Grown at 71.49%

over average net sales of the previous four periods of CNY 25.59 MM

MOJO Watch

Near term Pre-Tax Profit trend is positive

Pre-Tax Profit (CNY MM)

Net Profit

Highest at CNY 36.65 MM

in the last five periods

MOJO Watch

Near term Net Profit trend is positive

Net Profit (CNY MM)

EPS

Highest at CNY 0.06

in the last five periods

MOJO Watch

Increasing profitability; company has created higher earnings for shareholders

EPS (CNY)

Debtors Turnover Ratio

Highest at 11.98 times

in the last five Semi-Annual periods

MOJO Watch

Company has been able to sell its Debtors faster

Debtors Turnover Ratio

Raw Material Cost

Fallen by -8.27% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for Shandong Wohua Pharmaceutical Co., Ltd.

Interest

At CNY 0.04 MM has Grown at 22.02%

over previous Semi-Annual period

MOJO Watch

Rising interest cost signifies increased borrowings

Interest Paid (CNY MM)